Aller au contenu principal
Profil bibliographique

Jaime Swartzwelder

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
23Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Clinical Laboratory Practices and Quality ControlDiabetes, Cardiovascular Risks, and LipoproteinsComputational Drug Discovery MethodsSepsis Diagnosis and TreatmentForensic Toxicology and Drug Analysis

Les publications récentes

Accès ouvert 2025 article OpenAlex

422 Evaluation of Lipemia Interference in Immunoassays Using Native Patient Samples and Ultracentrifugation

Alecee Barnum, Aimee Agustin, Clint Walker, Michael D. Spencer et autres

Abstract Introduction/Objective Lipemia, characterized by elevated lipid content in blood samples, can interfere with laboratory assays. Traditional interference studies often employ spiking with synthetic lipid emulsions like Intralipid; however, these may not accurately represent the complexity of native lipemic samples, which can …

us (code pays fourni par la source)

0 citations American Journal of Clinical Pathology
Accès ouvert 2025 conference-abstract OpenAlex

A-371 Analytical Comparison of Point-of-Care and Laboratory-Based High-Sensitivity Troponin I Assays

Usman Sunusi, Melissa Gardner, Kendra Storer, Sandra J. VanVranken et autres

Abstract Background Cardiovascular disease, particularly acute coronary syndrome (ACS), imposes a significant burden on patients, clinicians, and healthcare systems. Chest pain is one of the most common reasons for emergency department (ED) visits worldwide, with suspected ACS cases accounting for approximately 10% …

us (code pays fourni par la source)

0 citations Clinical Chemistry
Accès ouvert 2024 conference-abstract OpenAlex

B-296 Assessment of Clozapine Assay on The Automated, High-performance Beckman AU Analyzer

Douglas McCormick, Cassandra G. Eubanks, Cheryl L. Walker, Jaime Swartzwelder et autres

Abstract Background Treatment-resistant schizophrenia (TRS) affects approximately one in three patients with schizophrenia. The timely initiation of clozapine therapy is crucial for achieving remission in TRS patients. However, long turnaround times (TATs) associated with sending clozapine tests to reference laboratories cause significant …

us (code pays fourni par la source)

0 citations Clinical Chemistry
2021 article OpenAlex

Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays.

Clint Walker, Aaron Shuster, Charlene Weber, Karen E. Gebhardt et autres

OBJECTIVE: In this study, we compared the Abbott Architect B.R.A.H.M.S procalcitonin (PCT) assay with the newly developed Siemens Atellica B.R.A.H.M.S PCT assay. METHODS: Residual 45 lithium heparin plasma/serum specimens were randomly selected from routine hospital orders, and PCT was measured on both …

us (code pays fourni par la source)

1 citation PubMed

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.